Industry NewsAbility of multi-drug resistant infection to evolve within cystic fibrosis patients highlights need for rapid treatment
Industry NewsIllumina and Kartos Therapeutics partner to develop an NGS-based TP53 companion diagnostic
Editorial ArticleTargeting protein-protein interactions (PPIs): Identifying PPI inhibitors for novel therapeutics